Telemetry Investments, L.L.C. - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
Telemetry Investments, L.L.C. ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$407
-100.0%
345,000
+93.3%
0.64%
-62.7%
Q3 2022$1,344,000
-23.2%
178,500
-35.8%
1.72%
-17.0%
Q2 2022$1,751,000
-1.0%
277,909
+30.5%
2.07%
-25.7%
Q1 2022$1,768,000
+28.6%
213,000
-19.6%
2.79%
+57.5%
Q4 2021$1,375,000
+5.5%
265,000
+35.8%
1.77%
+0.9%
Q3 2021$1,303,000
-1.7%
195,121
+25.4%
1.76%
-3.6%
Q2 2021$1,325,000
-0.5%
155,573
+3.4%
1.82%
+21.0%
Q1 2021$1,332,000
-15.9%
150,477
+16.8%
1.51%
-43.7%
Q4 2020$1,584,000
+56.5%
128,848
+3.6%
2.68%
+21.7%
Q3 2020$1,012,000
-32.0%
124,320
-19.8%
2.20%
-45.6%
Q2 2020$1,488,000
+54.8%
155,000
+9.7%
4.04%
+20.3%
Q1 2020$961,000
-52.5%
141,348
+4.0%
3.36%
-50.2%
Q4 2019$2,024,000
-9.0%
135,848
-37.4%
6.74%
+5.1%
Q3 2019$2,225,000
-44.2%
217,029
-42.3%
6.42%
+108.4%
Q2 2019$3,986,000
+100.6%
376,035
+164.6%
3.08%
+205.2%
Q1 2019$1,987,000
+28.4%
142,140
-6.7%
1.01%
+2.2%
Q4 2018$1,548,000
+239.5%
152,406
+301.1%
0.99%
+376.8%
Q3 2018$456,000
-4.2%
38,000
-2.6%
0.21%
+14.4%
Q2 2018$476,00039,0000.18%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders